Skip to main content
Equibles

Vanguard Global Advisers, LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1811242 MALVERN, PA
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$85,827
+$25,013 QoQ
Shares Held
16,348
0.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 98 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Vanguard Global Advisers, LLC holds $170,283,439 across 44 Drug Manufacturers - Specialty & Generic names. LFCR ranks #35 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 954,734 $68,607,185
2 VTRS
Viatris Inc
 2,699,149 $42,862,486
3 UTHR
UNITED THERAPEUTICS Corp
 17,345 $9,398,041
4 NBIX
Neurocrine Biosciences Inc
 38,679 $6,518,958
5 ELAN
Elanco Animal Health Inc
 200,037 $4,922,910
6 BHC
Bausch Health Companies Inc.
 855,700 $4,218,601
7 ALKS
Alkermes plc.
 63,665 $3,336,046
8 HIMS
Hims & Hers Health, Inc.
 81,988 $2,842,523

All Filings in LFCR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,827 16,348
2026-03-31 $60,814 16,348